SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Canadian Imperial Bank of Commerce/CAN – ‘40-F’ for 10/31/18 – ‘R25’

On:  Thursday, 11/29/18, at 7:22am ET   ·   For:  10/31/18   ·   Accession #:  1193125-18-337149   ·   File #:  1-14678

Previous ‘40-F’:  ‘40-F’ on 11/30/17 for 10/31/17   ·   Next:  ‘40-F’ on 12/5/19 for 10/31/19   ·   Latest:  ‘40-F’ on 11/30/23 for 10/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/29/18  Canadian Imperial B… Commerce/CAN 40-F       10/31/18  279:56M                                    Donnelley … Solutions/FA

Registration Statement or Annual Report by a Canadian Issuer   —   Form 40-F   —   Sect. 12 or 13(a) / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 40-F        Registration Statement or Annual Report by a        HTML    108K 
                Canadian Issuer                                                  
10: EX-99.B.10  Principal Accountant Fees and Services              HTML     84K 
11: EX-99.B.12  Tabular Disclosure of Contractual Obligations       HTML    140K 
 2: EX-99.B.3(A)  Annual Information Form                           HTML    292K 
 3: EX-99.B.3(B)  Audited Consolidated Financial Statements for     HTML   3.18M 
                the Year Ended October 31, 2018                                  
 4: EX-99.B.3(C)  Management's Discussion and Analysis              HTML   2.99M 
 5: EX-99.B.3(D)  Other Pages of Cibc's 2018 Annual Report          HTML    157K 
                Incorporated in Annual Information Form                          
 6: EX-99.B.6(A)(1)  Certifications Required by Rule 13A-14(A)      HTML     94K 
 7: EX-99.B.6(A)(2)  Certifications Required by Rule 13A-14(B)      HTML     89K 
 8: EX-99.B.8   Disclosure Regarding Audit Committee Financial      HTML     85K 
                Expert                                                           
 9: EX-99.B.9   Disclosure Regarding Code of Ethics                 HTML     87K 
12: EX-99.D.9   Consent of Independent Registered Public            HTML     88K 
                Accounting Firm                                                  
19: R1          Document and Entity Information                     HTML    107K 
20: R2          Consolidated balance sheet                          HTML    197K 
21: R3          Consolidated statement of income                    HTML    215K 
22: R4          Consolidated statement of income (Parenthetical)    HTML     89K 
23: R5          Consolidated statement of comprehensive income      HTML    220K 
24: R6          Consolidated statement of comprehensive income      HTML     90K 
                (Parenthetical)                                                  
25: R7          Consolidated statement of changes in equity         HTML    208K 
26: R8          Consolidated statement of changes in equity         HTML     89K 
                (Parenthetical)                                                  
27: R9          Consolidated statement of cash flows                HTML    217K 
28: R10         Consolidated statement of cash flows                HTML     89K 
                (Parenthetical)                                                  
29: R11         Basis of preparation and summary of significant     HTML    338K 
                accounting policies                                              
30: R12         Fair value measurement                              HTML    864K 
31: R13         Significant transactions                            HTML    125K 
32: R14         Securities                                          HTML    323K 
33: R15         Loans                                               HTML    502K 
34: R16         Structured entities and derecognition of financial  HTML    185K 
                assets                                                           
35: R17         Land, Buildings and Equipment                       HTML    132K 
36: R18         Goodwill, Software and Other Intangible Assets      HTML    191K 
37: R19         Other assets                                        HTML     97K 
38: R20         Deposits                                            HTML    121K 
39: R21         Other liabilities                                   HTML     99K 
40: R22         Derivative instruments                              HTML    398K 
41: R23         Designated accounting hedges                        HTML    260K 
42: R24         Subordinated indebtedness                           HTML    153K 
43: R25         Common and preferred share capital                  HTML    229K 
44: R26         Capital Trust securities                            HTML    111K 
45: R27         Share-based payments                                HTML    176K 
46: R28         Post-employment benefits                            HTML    332K 
47: R29         Income taxes                                        HTML    282K 
48: R30         Earnings per share                                  HTML    106K 
49: R31         Commitments, guarantees and pledged assets          HTML    147K 
50: R32         Contingent liabilities and provision                HTML    157K 
51: R33         Concentration of credit risk                        HTML    138K 
52: R34         Related-party transactions                          HTML    112K 
53: R35         Investments in equity-accounted associates and      HTML    111K 
                joint ventures                                                   
54: R36         Significant subsidiaries                            HTML    124K 
55: R37         Financial instruments - disclosures                 HTML    126K 
56: R38         Offsetting financial assets and liabilities         HTML    165K 
57: R39         Interest income and expense                         HTML    106K 
58: R40         Segmented and geographic information                HTML    322K 
59: R41         Future accounting policy changes                    HTML    101K 
60: R42         IFRS 7 Disclosure                                   HTML    822K 
61: R43         Basis of preparation and summary of significant     HTML    461K 
                accounting policies (Policies)                                   
62: R44         Basis of preparation and summary of significant     HTML    211K 
                accounting policies (Tables)                                     
63: R45         Fair value measurement (Tables)                     HTML    821K 
64: R46         Significant transactions (Tables)                   HTML    123K 
65: R47         Securities (Tables)                                 HTML    334K 
66: R48         Loans (Tables)                                      HTML    516K 
67: R49         Structured entities and derecognition of financial  HTML    141K 
                assets (Tables)                                                  
68: R50         Land, Buildings and Equipment (Tables)              HTML    132K 
69: R51         Goodwill, Software and Other Intangible Assets      HTML    173K 
                (Tables)                                                         
70: R52         Other assets (Tables)                               HTML     96K 
71: R53         Deposits (Tables)                                   HTML    120K 
72: R54         Other liabilities (Tables)                          HTML     98K 
73: R55         Derivative instruments (Tables)                     HTML    360K 
74: R56         Designated accounting hedges (Tables)               HTML    277K 
75: R57         Subordinated indebtedness (Tables)                  HTML    151K 
76: R58         Common and preferred share capital (Tables)         HTML    209K 
77: R59         Capital Trust securities (Tables)                   HTML    105K 
78: R60         Share-based payments (Tables)                       HTML    148K 
79: R61         Post-employment benefits (Tables)                   HTML    320K 
80: R62         Income taxes (Tables)                               HTML    272K 
81: R63         Earnings per share (Tables)                         HTML    106K 
82: R64         Commitments, guarantees and pledged assets          HTML    129K 
                (Tables)                                                         
83: R65         Contingent liabilities and provision (Tables)       HTML    106K 
84: R66         Concentration of credit risk (Tables)               HTML    136K 
85: R67         Related-party transactions (Tables)                 HTML    100K 
86: R68         Investments in equity-accounted associates and      HTML    103K 
                joint ventures (Tables)                                          
87: R69         Significant subsidiaries (Tables)                   HTML    124K 
88: R70         Financial instruments - disclosures (Tables)        HTML    118K 
89: R71         Offsetting financial assets and liabilities         HTML    165K 
                (Tables)                                                         
90: R72         Interest income and expense (Tables)                HTML    106K 
91: R73         Segmented and geographic information (Tables)       HTML    270K 
92: R74         Summary of Breakdown of Our Standardized Credit     HTML    126K 
                Risk Exposures by Risk-weight Category (Tables)                  
93: R75         IFRS 7 Disclosure (Tables)                          HTML    652K 
94: R76         Basis of Preparation and Summary of Significant     HTML    188K 
                Accounting Policies - Reconciliation of Closing                  
                Allowance for Credit Losses in Accordance with IAS               
                39 (Detail)                                                      
95: R77         Basis of Preparation and Summary of Significant     HTML    101K 
                accounting Policies - Additional Information                     
                (Detail)                                                         
96: R78         Basis of Preparation and Summary of Significant     HTML    101K 
                accounting Policies - Additional Information1                    
                (Detail)                                                         
97: R79         Basis of Preparation and Summary of Significant     HTML    307K 
                Accounting Policies - Reconciliation of Carrying                 
                Amounts Under IAS 39, Net of Tax on Shareholders'                
                Equity and Total Equity (Detail)                                 
98: R80         Basis of Preparation and Summary of Significant     HTML    108K 
                Accounting Policies - Reconciliation of Carrying                 
                Amounts Under IAS 39, Net of Tax on Shareholders'                
                Equity and Total Equity (Parenthetical) (Detail)                 
99: R81         Fair Value Measurement - Fair Value of Financial    HTML    291K 
                Instruments (Detail)                                             
100: R82         Fair Value Measurement - Fair Value of Derivative   HTML    208K  
                Financial Instruments (Detail)                                   
101: R83         Fair Value Measurement - Summary of Assets and      HTML    138K  
                Liabilities Not Carried On Consolidated Balance                  
                Sheet at Fair Value (Detail)                                     
102: R84         Fair Value Measurement - Summary of Financial       HTML    243K  
                Instruments Carried On Consolidated Balance Sheet                
                at Fair Value (Detail)                                           
103: R85         Fair Value Measurement - Summary of Financial       HTML    101K  
                Instruments Carried On Consolidated Balance Sheet                
                at Fair Value (Parenthetical) (Detail)                           
104: R86         Fair Value Measurement- Additional Information      HTML    124K  
                (Detail)                                                         
105: R87         Fair Value Measurement - Changes in Fair Value of   HTML    368K  
                Financial Assets and Liabilities in Level 3                      
                (Detail)                                                         
106: R88         Fair Value Measurement - Changes in Fair Value of   HTML     92K  
                Financial Assets and Liabilities in Level 3                      
                (Parenthetical) (Detail)                                         
107: R89         Fair Value Measurement - Valuation Techniques and   HTML    180K  
                Quantitative Information About Significant                       
                Non-observable Inputs Used In Level 3 Financial                  
                Instruments (Detail)                                             
108: R90         Significant Transactions - Additional information   HTML    175K  
                (Detail)                                                         
109: R91         Significant Transactions - Detailed Information of  HTML    102K  
                Business Acquisition (Detail)                                    
110: R92         Significant Transactions - Detailed Information of  HTML    118K  
                Business Acquisition (Parenthetical) (Detail)                    
111: R93         Significant Transactions - Disclosure of            HTML    129K  
                Preliminary Fair Values of Identifiable Assets                   
                Acquired and Liabilities Assumed at the                          
                Acquisition Date (Detail)                                        
112: R94         Significant Transactions - Disclosure of            HTML    101K  
                Preliminary Fair Values of Identifiable Assets                   
                Acquired and Liabilities Assumed at the                          
                Acquisition Date (Parenthetical) (Detail)                        
113: R95         Securities - Summary of Securities (Detail)         HTML    110K  
114: R96         Securities - Summary of Securities (Parenthetical)  HTML     88K  
                (Detail)                                                         
115: R97         Securities - Summary of Residual Term to            HTML    293K  
                Contractual Maturity of Financial Instruments                    
                (Detail)                                                         
116: R98         Securities - Summary of Residual Term to            HTML    166K  
                Contractual Maturity of Financial Instruments                    
                (Parenthetical) (Detail)                                         
117: R99         Securities - Schedule of Fair Value of Debt         HTML    161K  
                Securities Measured and Equity Securities                        
                Designated at FVOCI (Detail)                                     
118: R100        Securities - Schedule of Fair Value of Debt         HTML     89K  
                Securities Measured and Equity Securities                        
                Designated at FVOCI (Parenthetical) (Detail)                     
119: R101        Securities - Additional Information (Detail)        HTML    126K  
120: R102        Securities - Summary of Profit or Loss Recognized   HTML    107K  
                on FVOCI Securities (Detail)                                     
121: R103        Securities - Summary of Allowance for Losses        HTML    118K  
                measured at FVOCI (Detail)                                       
122: R104        Securities - Summary of Allowance for Losses        HTML     98K  
                measured at FVOCI (Parenthetical) (Detail)                       
123: R105        Loans - Disclosure of Loans and Receivables         HTML    162K  
                (Detail)                                                         
124: R106        Loans - Disclosure of Loans and Receivables         HTML    106K  
                (Parenthetical) (Detail)                                         
125: R107        Loans - Summary of Allowance for Credit Losses      HTML    225K  
                under IFRS 9 (Detail)                                            
126: R108        Loans - Summary of Allowance for Credit Losses      HTML    102K  
                under IFRS 9 (Parenthetical) (Detail)                            
127: R109        Loans - Summary of Allowance for Credit Losses      HTML    158K  
                under IAS 39 (Detail)                                            
128: R110        Loans - Additional Information (Detail)             HTML    119K  
129: R111        Loans - Summary of Base Case Forecasts for Select   HTML    109K  
                Forward Looking Information Variables Used to                    
                Estimate our Expected Credit Losses (Detail)                     
130: R112        Loans - Summary of Carrying Amount of Loans Based   HTML    217K  
                on Internal Risk Rating Grades (Detail)                          
131: R113        Loans - Summary of Carrying Amount of Loans Based   HTML    109K  
                on Internal Risk Rating Grades (Parenthetical)                   
                (Detail)                                                         
132: R114        Loans - Summary of Undrawn Credit Facilities and    HTML    209K  
                Other Off Balance Sheet Exposures (Detail)                       
133: R115        Loans - Summary of Credit Quality of Net Business   HTML    170K  
                and Government Loans and Acceptances (Detail)                    
134: R116        Loans - Summary of Credit Quality of Net Business   HTML     88K  
                and Government Loans and Acceptances                             
                (Parenthetical) (Detail)                                         
135: R117        Loans - Summary of Credit Quality of Net Retail     HTML    192K  
                Loans (Detail)                                                   
136: R118        Loans - Summary of Impaired Loans (Detail)          HTML    140K  
137: R119        Loans - Summary of Impaired Loans (Parenthetical)   HTML     96K  
                (Detail)                                                         
138: R120        Loans - Summary of Purchased Credit Impaired Loans  HTML    104K  
                (Detail)                                                         
139: R121        Loans - Schedule of Loans Past Due But Not          HTML    117K  
                Impaired (Detail)                                                
140: R122        Loans - Schedule of Net Interest Income After       HTML    100K  
                Provision for Credit Losses (Detail)                             
141: R123        Structured Entities and Derecognition of Financial  HTML    141K  
                Assets - Additional Information (Detail)                         
142: R124        Structured Entities and Derecognition of Financial  HTML    144K  
                Assets - Schedule of Unconsolidated Entity Balance               
                Sheet Amounts and Maximum Exposure to Loss                       
                (Detail)                                                         
143: R125        Structured Entities and Derecognition of Financial  HTML     92K  
                Assets - Schedule of Unconsolidated Entity Balance               
                Sheet Amounts and Maximum Exposure to Loss                       
                (Parenthetical) (Detail)                                         
144: R126        Structured Entities and Derecognition of Financial  HTML    108K  
                Assets - Schedule of Carrying Amount and Fair                    
                Value of Transferred Financial Assets that did not               
                Qualify for Derecognition and Associated Financial               
                Liabilities (Detail)                                             
145: R127        Structured Entities and Derecognition of Financial  HTML     92K  
                Assets - Schedule of Carrying Amount and Fair                    
                Value of Transferred Financial Assets that did not               
                Qualify for Derecognition and Associated Financial               
                Liabilities (Parenthetical) (Detail)                             
146: R128        Land, Buildings and Equipment - Summary of Land,    HTML    133K  
                Buildings and Equipment (Detail)                                 
147: R129        Land, Buildings and Equipment - Summary of Land,    HTML     91K  
                Buildings and Equipment (Parenthetical) (Detail)                 
148: R130        Land, Buildings and Equipment - Additional          HTML    109K  
                Information (Detail)                                             
149: R131        Land, Buildings and Equipment - Carrying Value of   HTML     93K  
                Finance Lease Property (Detail)                                  
150: R132        Goodwill, Software and Other Intangible Assets -    HTML    114K  
                Summary of Changes in Carrying Amount of Goodwill                
                by Cash Generating Units (Detail)                                
151: R133        Goodwill, Software and Other Intangible Assets -    HTML     98K  
                Summary of Changes in Carrying Amount of Goodwill                
                by Cash Generating Units (Parenthetical) (Detail)                
152: R134        Goodwill, Software and Other Intangible Assets -    HTML    161K  
                Additional Information (Detail)                                  
153: R135        Goodwill, Software and Other Intangible Assets -    HTML    102K  
                Schedule of Carrying Amount of Indefinite-lived                  
                Intangible Assets (Detail)                                       
154: R136        Goodwill, Software and Other Intangible Assets -    HTML    136K  
                Schedule of Components of Finite-lived Software                  
                and Other Intangible Assets (Detail)                             
155: R137        Goodwill, Software and Other Intangible Assets -    HTML     97K  
                Schedule of Components of Finite-lived Software                  
                and Other Intangible Assets (Parenthetical)                      
                (Detail)                                                         
156: R138        Other Assets - Summary of Other Assets (Detail)     HTML    108K  
157: R139        Deposits - Summary of Deposits and Components       HTML    139K  
                (Detail)                                                         
158: R140        Deposits - Summary of Deposits and Components       HTML    102K  
                (Parenthetical) (Detail)                                         
159: R141        Other Liabilities - Summary of Other liabilities    HTML    107K  
                (Detail)                                                         
160: R142        Derivative Instruments- Summary of Derivative       HTML    103K  
                Instruments (Detail)                                             
161: R143        Derivative Instruments - Summary of Notional        HTML    380K  
                Amounts (Detail)                                                 
162: R144        Derivative Instruments - Summary of Notional        HTML     93K  
                Amounts (Parenthetical) (Detail)                                 
163: R145        Derivative Instruments - Summary of Credit          HTML    219K  
                Exposure Arising from Derivatives (Detail)                       
164: R146        Derivative Instruments - Summary of Credit          HTML     96K  
                Exposure Arising from Derivatives (Parenthetical)                
                (Detail)                                                         
165: R147        Derivative Instruments - Additional Information     HTML     89K  
                (Detail)                                                         
166: R148        Designated accounting hedges - Summary of Items     HTML    192K  
                Designated as Hedging Instruments (Detail)                       
167: R149        Designated Accounting Hedges - Summary of Notional  HTML    105K  
                Amounts and Carrying Value of Our Hedging Related                
                Derivative Instruments (Detail)                                  
168: R150        Designated Accounting Hedges - Summary of Average   HTML    135K  
                Rate or Price of Hedging Instruments (Detail)                    
169: R151        Designated Accounting Hedges - Additional           HTML    109K  
                Information (Detail)                                             
170: R152        Designated Accounting Hedges - Summary of Items     HTML    142K  
                Designated as Hedged Items (Detail)                              
171: R153        Designated Accounting Hedges - Summary of Items     HTML     93K  
                Designated as Hedged Items (Parenthetical)                       
                (Detail)                                                         
172: R154        Designated Accounting Hedges - Summary of Hedge     HTML    137K  
                Accounting Impact on the Consolidated Statement of               
                Comprehensive Income (Detail)                                    
173: R155        Designated Accounting Hedges - Summary of Hedge     HTML    104K  
                Ineffectiveness Gains (Losses) Recognized in                     
                Consolidated Statement of Income (Detail)                        
174: R156        Designated Accounting Hedges - Summary of Periods   HTML     97K  
                when Cash Flows Designated as Hedged (Detail)                    
175: R157        Subordinated Indebtedness - Schedule of Terms of    HTML    176K  
                Subordinated Indebtedness (Detail)                               
176: R158        Subordinated Indebtedness - Schedule of Terms of    HTML    132K  
                Subordinated Indebtedness (Parenthetical) (Detail)               
177: R159        Common and Preferred Share Capital - Summary of     HTML    136K  
                Outstanding Shares and Dividends Paid (Detail)                   
178: R160        Common and Preferred Share Capital - Additional     HTML    206K  
                Information (Detail)                                             
179: R161        Common and Preferred Share Capital - Schedule of    HTML    138K  
                Common Shares Issued (Detail)                                    
180: R162        Common and Preferred Share Capital - Schedule of    HTML     95K  
                Common Shares Issued (Parenthetical) (Detail)                    
181: R163        Common and Preferred Share Capital - Schedule of    HTML     97K  
                Common Shares Purchased and Cancelled under                      
                Previously Expired NCIB (Detail)                                 
182: R164        Common and Preferred Share Capital - Schedule of    HTML     94K  
                Common Shares Purchased and Cancelled under                      
                Previously Expired NCIB (Parenthetical) (Detail)                 
183: R165        Common and Preferred Share Capital - Schedule of    HTML    105K  
                Terms of Class A Preferred Shares (Detail)                       
184: R166        Common and Preferred Share Capital - Schedule of    HTML    106K  
                Regulatory Capital and Ratios (Detail)                           
185: R167        Capital Trust Securities - Additional Information   HTML    109K  
                (Detail)                                                         
186: R168        Capital Trust Securities - Summary of Significant   HTML    105K  
                Terms and Conditions of Notes (Detail)                           
187: R169        Capital Trust Securities - Summary of Significant   HTML     99K  
                Terms and Conditions of Notes (Parenthetical)                    
                (Detail)                                                         
188: R170        Share-based Payments - Additional Information       HTML    199K  
                (Detail)                                                         
189: R171        Share-based Payments - Summary of Assumptions Used  HTML     99K  
                to Determine Fair Value of Options Granted                       
                (Detail)                                                         
190: R172        Share-based Payments - Summary of Stock Option      HTML    123K  
                Activity and Related Information (Detail)                        
191: R173        Share-based Payments - Summary of Stock Option      HTML     92K  
                Activity and Related Information (Parenthetical)                 
                (Detail)                                                         
192: R174        Share-based payments -Summary of Stock options      HTML    126K  
                outstanding and vested (Detail)                                  
193: R175        Post-Employment Benefits - Additional Information   HTML    102K  
                (Detail)                                                         
194: R176        Post-Employment Benefits - Summary of Financial     HTML    154K  
                Position Related to Defined Benefit Pensions and                 
                Other Post Employment Plans (Detail)                             
195: R177        Post-Employment Benefits - Summary of Financial     HTML     90K  
                Position Related to Defined Benefit Pensions and                 
                Other Post Employment Plans (Parenthetical)                      
                (Detail)                                                         
196: R178        Post-Employment Benefits - Summary of Defined       HTML    105K  
                Benefit Assets (Liability) Net of Valuation                      
                Allowance Included in Other Assets and Other                     
                Liabilities (Detail)                                             
197: R179        Post-Employment Benefits - Summary of Defined       HTML     94K  
                Benefit Assets (Liability) Net of Valuation                      
                Allowance Included in Other Assets and Other                     
                Liabilities (Parenthetical) (Detail)                             
198: R180        Post-Employment Benefits - Summary of Defined       HTML    107K  
                Benefit obligation and Plan Assets by Region                     
                (Detail)                                                         
199: R181        Post-Employment Benefits - Summary of Defined       HTML    116K  
                Benefit Plan Expense (Detail)                                    
200: R182        Post-Employment Benefits - Summary of Defined       HTML     89K  
                Benefit Plan Expense (Parenthetical) (Detail)                    
201: R183        Post-Employment Benefits - Summary of Net           HTML    111K  
                Remeasurement Gains (Losses) Recognized in OCI                   
                (Detail)                                                         
202: R184        Post-Employment Benefits - Summary of Net           HTML     91K  
                Remeasurement Gains (Losses) Recognized in OCI                   
                (Parenthetical) (Detail)                                         
203: R185        Post-Employment Benefits - Summary of Defined       HTML    106K  
                Benefit Obligation (Detail)                                      
204: R186        Post-Employment Benefits - Summary of Weighted      HTML     94K  
                Average Duration of Defined Benefit Obligation                   
                (Detail)                                                         
205: R187        Post-Employment Benefits - Summary of Major         HTML    147K  
                Categories of Defined Benefit Plan Assets (Detail)               
206: R188        Post-Employment Benefits - Summary of Major         HTML    100K  
                Categories of Defined Benefit Plan Assets                        
                (Parenthetical) (Detail)                                         
207: R189        Post-Employment Benefits - Summary of Weighted      HTML     98K  
                Average Principal Assumptions Used to Determine                  
                Defined Benefit Obligation (Detail)                              
208: R190        Post-Employment Benefits - Summary of Weighted      HTML     91K  
                Average Principal Assumptions Used to Determine                  
                Defined Benefit Obligation (Parenthetical)                       
                (Detail)                                                         
209: R191        Post-Employment Benefits - Summary of Longevities   HTML     99K  
                Underlying Values of Defined Benefit Obligation                  
                (Detail)                                                         
210: R192        Post-Employment Benefits - Summary of Assumed       HTML     96K  
                Health-care Cost Trend Rates (Detail)                            
211: R193        Post-Employment Benefits - Summary of Affected      HTML    109K  
                Defined Benefit Obligation Due to Reasonable                     
                Possible Changes to Principal Actuarial                          
                Assumptions (Detail)                                             
212: R194        Post-Employment Benefits - Summary of Expected      HTML    108K  
                Future Benefit Payments (Detail)                                 
213: R195        Post-Employment Benefits - Summary of defined       HTML     95K  
                contributions and other plans (Detail)                           
214: R196        Income Taxes - Total Income Taxes (Detail)          HTML    115K  
215: R197        Income Taxes - Components of Income Tax (Detail)    HTML    104K  
216: R198        Income Taxes - Reconciliation of Income Taxes       HTML    126K  
                (Detail)                                                         
217: R199        Income Taxes - Sources and Movement in Deferred     HTML    226K  
                Tax Assets and Liabilities (Detail)                              
218: R200        Income Taxes - Sources and Movement in Deferred     HTML     94K  
                Tax Assets and Liabilities (Parenthetical)                       
                (Detail)                                                         
219: R201        Income Taxes - Additional Information (Detail)      HTML    136K  
220: R202        Earnings per Share - Summary of Earnings Per Share  HTML    111K  
                (Detail)                                                         
221: R203        Earnings per Share - Summary of Earnings Per Share  HTML     91K  
                (Parenthetical) (Detail)                                         
222: R204        Commitments, Guarantees and Pledged Assets -        HTML    100K  
                Summary of Contract Amounts of Credit-Related                    
                Arrangements (Detail)                                            
223: R205        Commitments, Guarantees and Pledged Assets -        HTML     94K  
                Summary of Contract Amounts of Credit-Related                    
                Arrangements (Parenthetical) (Detail)                            
224: R206        Commitments, Guarantees and Pledged Assets -        HTML    104K  
                Additional Information (Detail)                                  
225: R207        Commitments, Guarantees and Pledged Assets -        HTML    112K  
                Summary of Future Minimum Lease Payments and                     
                Receipt for Operating Lease Commitments (Detail)                 
226: R208        Commitments, Guarantees and Pledged Assets -        HTML     91K  
                Summary of Future Minimum Lease Payments and                     
                Receipt for Operating Lease Commitments                          
                (Parenthetical) (Detail)                                         
227: R209        Commitments, Guarantees and Pledged Assets -        HTML    108K  
                Summary of Future Minimum Lease Payments for                     
                Finance Lease Commitments (Detail)                               
228: R210        Commitments, Guarantees and Pledged Assets -        HTML     89K  
                Summary of Future Minimum Lease Payments for                     
                Finance Lease Commitments (Parenthetical) (Detail)               
229: R211        Commitments, Guarantees and Pledged Assets -        HTML    112K  
                Summary of Asset Pledging Amounts and Related                    
                Activities (Detail)                                              
230: R212        Contingent Liabilities and Provision - Additional   HTML    140K  
                Information (Detail)                                             
231: R213        Contingent Liabilities and Provision - Disclosure   HTML     98K  
                of Changes in Legal Provisions (Detail)                          
232: R214        Contingent Liabilities and Provision - Disclosure   HTML     98K  
                of Changes in the Restructuring Provision (Detail)               
233: R215        Concentration of Credit Risk - Summary of Credit    HTML    162K  
                Exposure Associated with our On- and Off-Balance                 
                Sheet Financial Instruments (Detail)                             
234: R216        Concentration of Credit Risk - Summary of Credit    HTML    106K  
                Exposure Associated with our On- and Off-Balance                 
                Sheet Financial Instruments (Parenthetical)                      
                (Detail)                                                         
235: R217        Related-Party Transactions - Additional             HTML     99K  
                Information (Detail)                                             
236: R218        Related-Party Transactions - Summary of             HTML    104K  
                Compensation of Key Management Personnel (Detail)                
237: R219        Investments in Equity-Accounted Associates and      HTML    148K  
                Joint Ventures - Additional Information (Detail)                 
238: R220        Investments in Equity-Accounted Associates and      HTML    100K  
                Joint Ventures - Summary of Aggregate Financial                  
                Information Related to Proportionate Interest in                 
                the Equity-accounted Joint Ventures (Detail)                     
239: R221        Investments in Equity-Accounted Associates and      HTML    100K  
                Joint Ventures - Summary of Aggregate Financial                  
                Information Related to Proportionate Interest in                 
                Equity-Accounted Associates (Detail)                             
240: R222        Significant Subsidiaries - Additional Information   HTML     90K  
                (Detail)                                                         
241: R223        Significant Subsidiaries - Summary List of          HTML    211K  
                Significant Subsidiaries (Detail)                                
242: R224        Significant Subsidiaries - Summary List of          HTML    124K  
                Significant Subsidiaries (Parenthetical) (Detail)                
243: R225        Financial Instruments -Schedule of Balance Sheet    HTML    135K  
                Exposure Credit Risk under Different Basel                       
                Approaches (Detail)                                              
244: R226        Offsetting Financial Assets and Liabilities -       HTML    171K  
                Schedule of Financial Assets and Liabilities                     
                (Detail)                                                         
245: R227        Offsetting Financial Assets and Liabilities -       HTML     89K  
                Schedule of Financial Assets and Liabilities                     
                (Parenthetical) (Detail)                                         
246: R228        Interest income and expense - Summary of            HTML    113K  
                Consolidated Interest Income and Expense for Both                
                Product and Accounting Categories (Detail)                       
247: R229        Segmented and Geographic Information - Detailed     HTML    198K  
                Report of Segments and Geographic Areas (Detail)                 
248: R230        Segmented and Geographic Information - Detailed     HTML     93K  
                Report of Segments and Geographic Areas                          
                (Parenthetical) (Detail)                                         
249: R231        Segmented and Geographic Information - Breakdown    HTML    126K  
                of revenue from reporting segments (Detail)                      
250: R232        Segmented and Geographic Information - Breakdown    HTML     93K  
                of revenue from reporting segments (Parenthetical)               
                (Detail)                                                         
251: R233        IFRS 7 - Disclosure - Credit Risk - Summary of      HTML    115K  
                Risk Measurement (Detail)                                        
252: R234        IFRS 7 - Disclosure - Credit Risk - Summary of PD   HTML    107K  
                Bands to Various Risk Levels (Detail)                            
253: R235        IFRS 7 - Disclosure - Credit Risk - Summary of      HTML    251K  
                Exposure to Credit Risk (Detail)                                 
254: R236        IFRS 7 - Disclosure - Credit Risk - Additional      HTML    116K  
                Information (Detail)                                             
255: R237        IFRS 7 - Disclosure - Credit Risk - Summary of      HTML    158K  
                Breakdown of Our Standardized Credit Risk                        
                Exposures by Risk-weight Category (Detail)                       
256: R238        IFRS 7 - Disclosure - Credit Risk - Summary of      HTML    104K  
                Rating Profile of OTC Derivative Mark to Market                  
                (MTM) Receivables (Detail)                                       
257: R239        IFRS 7 - Disclosure - Credit Risk- Summary of       HTML    140K  
                Geographic Distribution of Business and Government               
                Exposures Under the AIRB Approach (Detail)                       
258: R240        IFRS 7 - Disclosure - Credit Risk - Summary of      HTML    257K  
                Industry-wide Breakdown of Business and Government               
                Exposure (Detail)                                                
259: R241        IFRS 7 - Disclosure - Credit Risk - Summary of      HTML     94K  
                Industry-wide Breakdown of Business and Government               
                Exposure (Parenthetical) (Detail)                                
260: R242        IFRS 7 - Disclosure - Credit Risk - Summary of      HTML    182K  
                Credit Quality of Risk-rated Portfolios Exposure                 
                (Detail)                                                         
261: R243        IFRS 7 - Disclosure - Credit Risk - Summary of      HTML    139K  
                Credit Quality of Retail Portfolios (Detail)                     
262: R244        IFRS 7 - Disclosure - Credit Risk - Summary of      HTML    104K  
                Securitization Exposures (Detail)                                
263: R245        IFRS 7 - Disclosure - Credit Risk - Summary of      HTML     91K  
                Securitization Exposures (Parenthetical) (Detail)                
264: R246        IFRS 7 - Disclosure - Market Risk - Additional      HTML    118K  
                Information (Detail)                                             
265: R247        IFRS 7 - Disclosure - Market Risk - Summary of      HTML    129K  
                Market Risks by Type of Risks (Detail)                           
266: R248        IFRS 7 - Disclosure - Market Risk - Summary of      HTML    129K  
                Stressed Value At Risk by Trading Activities                     
                (Detail)                                                         
267: R249        IFRS 7 - Disclosure - Market Risk - Summary of      HTML    105K  
                Incremental Risk Charge by Trading Activities                    
                (Detail)                                                         
268: R250        IFRS 7 - Disclosure - Market Risk - Summary of      HTML    101K  
                Structural Interest Rate Sensitivity - Measures                  
                (Detail)                                                         
269: R251        IFRS 7 - Disclosure - Market Risk - Summary of      HTML    106K  
                Amortized Cost and Fair Values of Non-trading                    
                Equities (Detail)                                                
270: R252        IFRS 7 - Disclosure - Liquidity Risk - Summary of   HTML    127K  
                Encumbered and Unencumbered Assets from On- and                  
                Off-Balance Sheet Sources (Detail)                               
271: R253        IFRS 7 - Disclosure - Liquidity Risk - Additional   HTML     88K  
                Information (Detail)                                             
272: R254        IFRS 7 - Disclosure - Liquidity Risk - Summary of   HTML    255K  
                Contractual Maturity Profile of On-Balance Sheet                 
                Assets, Liabilities and Equity at their Carrying                 
                Values (Detail)                                                  
273: R255        IFRS 7 - Disclosure - Liquidity Risk - Summary of   HTML    104K  
                Contractual Maturity Profile of On-Balance Sheet                 
                Assets, Liabilities and Equity at their Carrying                 
                Values (Parenthetical) (Detail)                                  
274: R256        IFRS 7 - Disclosure - Liquidity Risk - Summary of   HTML    172K  
                Credit Related Commitments (Detail)                              
275: R257        IFRS 7 - Disclosure - Liquidity Risk - Summary of   HTML     95K  
                Credit Related Commitments (Parenthetical)                       
                (Detail)                                                         
276: R258        IFRS 7 - Disclosure - Liquidity Risk - Summary of   HTML    161K  
                Contractual Maturities of Other Contractual                      
                Obligations Affecting Our Funding Needs (Detail)                 
278: XML         IDEA XML File -- Filing Summary                      XML    577K  
277: EXCEL       IDEA Workbook of Financial Reports                  XLSX    515K  
13: EX-101.INS  XBRL Instance -- cm-20181031                         XML  23.36M 
15: EX-101.CAL  XBRL Calculations -- cm-20181031_cal                 XML    807K 
16: EX-101.DEF  XBRL Definitions -- cm-20181031_def                  XML   4.27M 
17: EX-101.LAB  XBRL Labels -- cm-20181031_lab                       XML   5.84M 
18: EX-101.PRE  XBRL Presentations -- cm-20181031_pre                XML   5.30M 
14: EX-101.SCH  XBRL Schema -- cm-20181031                           XSD   1.22M 
279: ZIP         XBRL Zipped Folder -- 0001193125-18-337149-xbrl      Zip   1.19M  


‘R25’   —   Common and preferred share capital


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.10.0.1
Common and preferred share capital
12 Months Ended
Text block1 [abstract]  
Common and preferred share capital
Note  15   Common and preferred share capital

 

The following table presents the outstanding number of shares and dividends paid:

Outstanding shares and dividends paid

 

$ millions, except number of shares and per share
amounts, as at or for the year ended October 31
    2018                          2017                          2016  
     Shares outstanding     Dividends paid     Shares outstanding     Dividends paid     Shares outstanding     Dividends paid  
     Number
of shares
    Amount     Amount     $ per
share
    Number
of shares
    Amount     Amount     $ per
share
    Number
of shares
    Amount     Amount     $ per
share
 

Common shares

    442,823,361   $ 13,242   $     2,356   $     5.32       439,329,713   $   12,550   $   2,121   $   5.08     397,055,398   $   8,025   $   1,879   $   4.75

Class A Preferred Shares

                       

Series 39

    16,000,000     400     16     0.98     16,000,000     400     16     0.98     16,000,000     400     16     0.98

Series 41

    12,000,000     300     11     0.94     12,000,000     300     11     0.94     12,000,000     300     11     0.94

Series 43

    12,000,000     300     11     0.90     12,000,000     300     11     0.90     12,000,000     300     11     0.90

Series 45

    32,000,000     800     35     1.10     32,000,000     800     14     0.46                

Series 47

    18,000,000     450     16       0.88                                  
            $     2,250   $ 89                   $ 1,800   $ 52                   $ 1,000   $ 38        

Treasury shares –common shares

    3,019   $ 1         (16,410   $ (2         14,882   $ 1    

Treasury shares –preferred shares

                            (116,671     (3                                        

Common shares

CIBC’s authorized capital consists of an unlimited number of common shares, without nominal or par value.

Common shares issued

 

$ millions, except number of shares, as at or for the year ended October 31     2018             2017              2016  
      Number
of shares
    Amount     Number
of shares
     Amount      Number
of shares
     Amount  

Balance at beginning of year

     439,313,303   $ 12,548     397,070,280    $ 8,026      397,291,068    $ 7,813

Issuance pursuant to:

               

Acquisition of The PrivateBank

     1,689,450     194     32,137,402      3,443          

Acquisition of Geneva Advisors

             1,204,344      126          

Acquisition of Wellington Financial

     378,848     47                   

Equity-settled share-based compensation plans

     999,675     95     990,934      91      815,767      72

Shareholder investment plan (1)

     2,880,782     337     6,870,584      749      1,662,972      164

Employee share purchase plan (2)

     1,044,893     123     1,071,051      117      373,382      37
     446,306,951     $ 13,344     439,344,595    $ 12,552      400,143,189    $ 8,086

Purchase of common shares for cancellation

     (3,500,000 )     (104 )               (3,081,300      (61

Treasury shares

     19,429     3     (31,292      (4      8,391      1

Balance at end of year (3)

     442,826,380     $     13,243     439,313,303  (4)     $     12,548        397,070,280    $     8,026

 

(1)

Commencing on October 28, 2016, CIBC has met the requirements for additional common shares for the Shareholder Investment Plan (the Plan) by issuing shares from Treasury. The participants in the Dividend Reinvestment Option and the Stock Dividend Option of the Plan received a 2% discount to average market price on dividends reinvested in additional common shares. Effective with the dividends paid on April 27, 2018, the discount was removed. The participants in the Share Purchase Option of the Plan continue to receive shares issued from Treasury with no discount.

(2)

Commencing June 29, 2016, employee contributions to our Canadian ESPP have been used to purchase common shares from Treasury.

(3)

Excludes 60,764 restricted shares as at October 31, 2018 (2017: 190,285; 2016: nil).

(4)

Excludes 2,010,890 common shares which were issued and outstanding but which had not been acquired by a third party as at October 31, 2017. These shares were issued as a component of our acquisition of The PrivateBank.

Common shares reserved for issue

As at October 31, 2018, 15,703,861 common shares (2017: 6,654,170) were reserved for future issue pursuant to stock option plans, 16,160,842 common shares (2017: 19,041,624) were reserved for future issue pursuant to the Shareholder Investment Plan, 3,043,087 common shares (2017: 2,771,650) were reserved for future issue pursuant to the employee share purchase plan and other activities, and 1,561,767,500 common shares (2017: 1,012,992,500) were reserved for future issue pursuant to instruments which include an NVCC provision requiring conversion into common shares upon the occurrence of a Trigger Event as described in the capital adequacy guidelines.

Normal course issuer bid

On May 31, 2018, we announced that the Toronto Stock Exchange (TSX) had accepted the notice of CIBC’s intention to commence a normal course issuer bid (NCIB). Purchases under this bid will terminate upon the earlier of: (i) CIBC purchasing up to a maximum of 9 million common shares; (ii) CIBC providing a notice of termination; or (iii) June 3, 2019. During the year, we purchased and cancelled 3,500,000 common shares under this bid at an average price of $119.22 for a total amount of $417 million.

The following table shows common shares purchased and cancelled under previously expired NCIBs.

 

$ millions, except number of shares, as at or for the year ended October 31      2018              2017              2016  
TSX approval date    Number
of shares
     Amount      Number
of shares
     Amount      Number
of shares
     Amount  

September 16, 2015 (1)

        $         $      3,081,300    $ 270

March 10, 2017 (2)

                               
          $     –           $     –        3,081,300    $     270

 

(1)

Common shares were repurchased at an average price of $87.83 under this NCIB, including 1,400,000 common shares purchased and cancelled under a private agreement at an average price of $86.94 for a total amount of $122 million on January 8, 2016.

(2)

No common shares were repurchased under this NCIB.

 

Preferred shares

CIBC is authorized to issue an unlimited number of Class A Preferred Shares and Class B Preferred Shares without nominal or par value, issuable in series, provided that, for each class of preferred shares, the maximum aggregate consideration for all outstanding shares, at any time does not exceed $10 billion. There are no Class B Preferred Shares currently outstanding.

Preferred share rights and privileges

Class A Preferred Shares

Each series of Class A Preferred Shares bears quarterly non-cumulative dividends. Non-cumulative Rate Reset Class A Preferred Shares Series 39, 41, 43, 45, and 47 (NVCC) are redeemable, subject to regulatory approval if required, for cash by CIBC on or after the specified redemption dates at the cash redemption prices indicated in the terms of the preferred shares.

Non-cumulative Rate Reset Class A Preferred Shares Series 47 (NVCC) (Series 47 shares)

On January 18, 2018, we issued 18 million Non-cumulative Rate Reset Class A Preferred Shares Series 47 (NVCC) (Series 47 shares) with a par value of $25.00 per share, for gross proceeds of $450 million. For the initial five-year period to the earliest redemption date of January 31, 2023, the Series 47 shares pay quarterly cash dividends, if declared, at a rate of 4.50%. On January 31, 2023, and on January 31 every five years thereafter, the dividend rate will reset to be equal to the then current five-year Government of Canada bond yield plus 2.45%.

Holders of the Series 47 shares will have the right to convert their shares on a one-for-one basis into Non-cumulative Floating Rate Class A Preferred Shares Series 48 (NVCC) (Series 48 shares), subject to certain conditions, on January 31, 2023 and on January 31 every five years thereafter. Holders of the Series 48 shares will be entitled to receive a quarterly floating rate dividend, if declared, equal to the three-month Government of Canada Treasury Bill yield plus 2.45%. Holders of the Series 48 shares may convert their shares on a one-for-one basis into Series 47 shares, subject to certain conditions, on January 31, 2028 and on January 31 every five years thereafter.

Subject to regulatory approval and certain provisions of the shares, we may redeem all or any part of the then outstanding Series 47 shares at par on January 31, 2023 and on January 31 every five years thereafter; we may redeem all or any part of the then outstanding Series 48 shares at par on January 31, 2028 and on January 31 every five years thereafter.

Non-cumulative Rate Reset Class A Preferred Shares Series 45 (NVCC) (Series 45 shares)

On June 2, 2017, we issued 32 million Series 45 shares with a par value of $25.00 per share, for gross proceeds of $800 million. For the initial five-year period to the earliest redemption date of July 31, 2022, the Series 45 shares pay quarterly cash dividends, if declared, at a rate of 4.40%. On July 31, 2022, and on July 31 every five years thereafter, the dividend rate will reset to be equal to the then current five-year Government of Canada bond yield plus 3.38%.

Holders of the Series 45 shares will have the right to convert their shares on a one-for-one basis into Non-cumulative Floating Rate Class A Preferred Shares Series 46 (NVCC) (Series 46 shares), subject to certain conditions, on July 31, 2022 and on July 31 every five years thereafter. Holders of the Series 46 shares will be entitled to receive a quarterly floating rate dividend, if declared, equal to the three-month Government of Canada Treasury Bill yield plus 3.38%. Holders of the Series 46 shares may convert their shares on a one-for-one basis into Series 45 shares, subject to certain conditions, on July 31, 2027 and on July 31 every five years thereafter.

Subject to regulatory approval and certain provisions of the shares, we may redeem all or any part of the then outstanding Series 45 shares at par on July 31, 2022 and on July 31 every five years thereafter; we may redeem all or any part of the then outstanding Series 46 shares at par on July 31, 2027 and on July 31 every five years thereafter.

Non-cumulative Rate Reset Class A Preferred Shares Series 43 (NVCC) (Series 43 shares)

On March 11, 2015, we issued 12 million Series 43 shares with a par value of $25.00 per share, for gross proceeds of $300 million. For the initial five-year period to the earliest redemption date of July 31, 2020, the Series 43 shares pay quarterly cash dividends, if declared, at a rate of 3.60%. On July 31, 2020, and on July 31 every five years thereafter, the dividend rate will reset to be equal to the then current five-year Government of Canada bond yield plus 2.79%.

Holders of the Series 43 shares will have the right to convert their shares on a one-for-one basis into Non-cumulative Floating Rate Class A Preferred Shares Series 44 (NVCC) (Series 44 shares), subject to certain conditions, on July 31, 2020 and on July 31 every five years thereafter. Holders of the Series 44 shares will be entitled to receive a quarterly floating rate dividend, if declared, equal to the three-month Government of Canada Treasury Bill yield plus 2.79%. Holders of the Series 44 shares may convert their shares on a one-for-one basis into Series 43 shares, subject to certain conditions, on July 31, 2025 and on July 31 every five years thereafter.

Subject to regulatory approval and certain provisions of the shares, we may redeem all or any part of the then outstanding Series 43 shares at par on July 31, 2020 and on July 31 every five years thereafter; we may redeem all or any part of the then outstanding Series 44 shares at par on July 31, 2025 and on July 31 every five years thereafter.

Non-cumulative Rate Reset Class A Preferred Shares Series 41 (NVCC) (Series 41 shares)

On December 16, 2014, we issued 12 million Series 41 shares with a par value of $25.00 per share, for gross proceeds of $300 million. For the initial five-year period to the earliest redemption date of January 31, 2020, the Series 41 shares pay quarterly cash dividends, if declared, at a rate of 3.75%. On January 31, 2020, and on January 31 every five years thereafter, the dividend rate will reset to be equal to the then current five-year Government of Canada bond yield plus 2.24%.

Holders of the Series 41 shares will have the right to convert their shares on a one-for-one basis into Non-cumulative Floating Rate Class A Preferred Shares Series 42 (NVCC) (Series 42 shares), subject to certain conditions, on January 31, 2020 and on January 31 every five years thereafter. Holders of the Series 42 shares will be entitled to receive a quarterly floating rate dividend, if declared, equal to the three-month Government of Canada Treasury Bill yield plus 2.24%. Holders of the Series 42 shares may convert their shares on a one-for-one basis into Series 41 shares, subject to certain conditions, on January 31, 2025 and on January 31 every five years thereafter.

Subject to regulatory approval and certain provisions of the shares, we may redeem all or any part of the then outstanding Series 41 shares at par on January 31, 2020 and on January 31 every five years thereafter; we may redeem all or any part of the then outstanding Series 42 shares at par on January 31, 2025 and on January 31 every five years thereafter.

Non-cumulative Rate Reset Class A Preferred Shares Series 39 (NVCC) (Series 39 shares)

On June 11, 2014, we issued 16 million Series 39 shares with a par value of $25.00 per share, for gross proceeds of $400 million. For the initial five-year period to the earliest redemption date of July 31, 2019, the Series 39 shares pay quarterly cash dividends, if declared, at a rate of 3.90%. On July 31, 2019, and on July 31 every five years thereafter, the dividend rate will reset to be equal to the then current five-year Government of Canada bond yield plus 2.32%.

Holders of the Series 39 shares will have the right to convert their shares on a one-for-one basis into Non-cumulative Floating Rate Class A Preferred Shares Series 40 (NVCC) (Series 40 shares), subject to certain conditions, on July 31, 2019 and on July 31 every five years thereafter. Holders of the Series 40 shares will be entitled to receive a quarterly floating rate dividend, if declared, equal to the three-month Government of Canada Treasury Bill yield plus 2.32%. Holders of the Series 40 shares may convert their shares on a one-for-one basis into Series 39 shares, subject to certain conditions, on July 31, 2024 and on July 31 every five years thereafter.

Subject to regulatory approval and certain provisions of the shares, we may redeem all or any part of the then outstanding Series 39 shares at par on July 31, 2019, and on July 31 every five years thereafter; we may redeem all or any part of the then outstanding Series 40 shares at par on July 31, 2024, and on July 31 every five years thereafter.

Series 39, Series 40, Series 41, Series 42, Series 43, Series 44, Series 45, Series 46, Series 47, and Series 48 shares are subject to an NVCC provision, necessary for the shares to qualify as regulatory capital under Basel III. As such, the shares are automatically converted into common shares upon the occurrence of a “Trigger Event”. As described in the Capital Adequacy Guidelines, a Trigger Event occurs when OSFI determines the bank is or is about to become non-viable and, if after conversion of all contingent instruments and consideration of any other relevant factors or circumstances, it is reasonably likely that its viability will be restored or maintained; or if the bank has accepted or agreed to accept a capital injection or equivalent support from a federal or provincial government, without which OSFI would have determined the bank to be non-viable. Each such share is convertible into a number of common shares, determined by dividing the par value of $25.00 plus declared and unpaid dividends by the average common share price (as defined in the relevant prospectus supplement) subject to a minimum price of $5.00 per share (subject to adjustment in certain events as defined in the relevant prospectus supplement). We have recorded the Series 39, Series 41, Series 43, Series 45, and Series 47 shares as equity.

Terms of Class A Preferred Shares

 

Outstanding as at October 31, 2018    Quarterly
dividends per share  (1)
     Earliest specified
redemption date
     Cash redemption
price per share
 

Series 39

   $ 0.243750        July 31, 2019      $ 25.00

Series 41

   $ 0.234375        January 31, 2020      $ 25.00

Series 43

   $ 0.225000        July 31, 2020      $ 25.00

Series 45

   $ 0.275000        July 31, 2022      $ 25.00

Series 47

   $     0.281250        January 31, 2023      $     25.00

 

(1)

Quarterly dividends may be adjusted depending on the timing of issuance or redemption.

Restrictions on the payment of dividends

Under Section 79 of the Bank Act (Canada), a bank, including CIBC, is prohibited from declaring or paying any dividends on its preferred or common shares if there are reasonable grounds for believing that the bank is, or the payment would cause it to be, in contravention of any capital adequacy or liquidity regulation or any direction to the bank made by OSFI.

In addition, our ability to pay common share dividends is also restricted by the terms of the outstanding preferred shares. These terms provide that we may not pay dividends on our common shares at any time without the approval of holders of the outstanding preferred shares, unless all dividends to preferred shareholders that are then payable have been declared and paid or set apart for payment.

We have agreed that if CIBC Capital Trust fails to pay any interest payments on its $1,300 million of CIBC Tier 1 Notes – Series A, due June 30, 2108 or its $300 million of CIBC Tier 1 Notes – Series B, due June 30, 2108, we will not declare dividends of any kind on any of our preferred or common shares for a specified period of time. For additional details see Note 16.

Currently, these limitations do not restrict the payment of dividends on our preferred or common shares.

Capital

Objectives, policy and procedures

Our objective is to employ a strong and efficient capital base. We manage capital in accordance with a capital policy approved by the Board. The policy includes specific guidelines that relate to capital strength, capital mix, dividends and return of capital, and the unconsolidated capital adequacy of regulated entities and capital is monitored continuously for compliance.

Each year, a Capital Plan and three-year outlook are established as a part of the financial plan, and they encompass all material elements of capital: forecasts of sources and uses of capital including earnings, dividends, business growth, and corporate initiatives, as well as maturities, redemptions, and issuances of capital instruments. The Capital Plan is stress-tested to ensure that it is sufficiently robust under severe but plausible stress scenarios. The level of capital and capital ratios are monitored throughout the year including a comparison to the Capital Plan. There were no significant changes made to the objectives, policy, guidelines and procedures during the year.

Regulatory capital requirements under Basel III

Our regulatory capital requirements are determined in accordance with guidelines issued by OSFI, which are based on the risk-based capital standards developed by the Basel Committee on Banking Supervision (BCBS).

CIBC has been designated by OSFI as a D-SIB in Canada, and is subject to a CET1 surcharge equal to 1.0% of risk-weighted assets (RWAs). In June 2018, OSFI publicly disclosed that it requires D-SIBs to hold a Domestic Stability Buffer, currently set at 1.5% of RWAs. This results in current all-in targets, including all buffer requirements, for CET1, Tier 1 and Total capital ratios of 9.5%, 11.0%, and 13.0%, respectively. These targets may be higher for certain institutions at OSFI’s discretion.

“All-in” is defined by OSFI as capital calculated to include all of the regulatory adjustments that will be required by 2019, but retaining the phase-out rules for non-qualifying capital instruments. Certain deductions from CET1 capital that were phased in at 20% per year from 2014 for the calculation of capital under the transitional rules are now fully deducted, and therefore, there is no longer a determination of transitional capital.

Regulatory capital and ratios

Regulatory capital under Basel III consists of CET1, Tier 1 and Tier 2 capital.

CET1 capital includes common shares, retained earnings, AOCI (excluding AOCI relating to cash flow hedges and changes to FVO liabilities attributable to changes in own credit risk), and qualifying instruments issued by a consolidated banking subsidiary to third parties, less regulatory adjustments for items such as goodwill and other intangible assets (net of related deferred tax liabilities), certain deferred tax assets, net assets related to defined benefit pension plans as reported on our consolidated balance sheet (net of related deferred tax liabilities), and certain investments. Additional Tier 1 (AT1) capital primarily includes NVCC preferred shares, qualifying instruments issued by a consolidated subsidiary to third parties, and non-qualifying innovative Tier 1 notes subject to phase-out rules for capital instruments. Tier 2 capital includes NVCC subordinated indebtedness, non-qualifying subordinated indebtedness subject to phase-out rules for capital instruments, eligible collective allowance under the standardized approach, and qualifying instruments issued by a consolidated subsidiary to third parties.

Our capital ratios and leverage ratio are presented in the table below:

 

$ millions, as at October 31        2018     2017  

All-in basis

     

CET1 capital

    $     24,641   $ 21,618

Tier 1 capital

  C     27,908     24,682

Total capital

      32,230     28,129

CET1 capital RWA (1)

      216,144     203,321

Tier 1 capital RWA (1)

      216,303     203,321

Total capital RWA (1)

      216,462     203,321

CET1 ratio

      11.4  %      10.6  % 

Tier 1 capital ratio

      12.9  %      12.1  % 

Total capital ratio

      14.9  %      13.8  % 

Leverage ratio exposure

  D   $     653,946   $     610,353

Leverage ratio

  C/D     4.3  %      4.0  % 

 

(1)

Before any capital floor requirement as applicable, there are three different levels of risk-weighted assets (RWAs) for the calculation of the CET1, Tier 1, and Total capital ratios arising from the option CIBC has chosen for the phase-in of the CVA capital charge. Since the introduction of Basel II in 2008, OSFI has prescribed a capital floor requirement for institutions that use the AIRB approach for credit risk. Effective in the second quarter of 2018, the capital floor is determined by comparing a capital requirement calculated by reference to the Basel II standardized approach against the Basel III calculation, as specified by OSFI. Any shortfall in the Basel III capital requirement compared with the floor factor applied to the capital requirements under the Basel II standardized approach is added to RWAs (75% is the floor factor in the fourth quarter of 2018). Prior to the second quarter of 2018, the capital floor for banks using the AIRB approach for credit risk was determined by reference to the Basel I instead of the Basel II standardized approach calculation. All-in RWAs as at October 31, 2017 included a capital floor adjustment under this methodology.

During the years ended October 31, 2018 and 2017, we have complied with OSFI’s regulatory capital requirements, including a 1.5% Domestic Stability Buffer since June 2018.


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘40-F’ Filing    Date    Other Filings
1/31/28
7/31/27
7/31/25
1/31/25
7/31/24
1/31/23
7/31/22
7/31/20424B2,  FWP
1/31/20FWP
7/31/19424B2
6/3/19424B2,  FWP
Filed on:11/29/186-K
For Period end:10/31/18
5/31/186-K,  FWP
4/27/18424B2
1/18/18424B2,  FWP
10/31/1740-F,  424B2,  424B3
6/2/17424B2,  424B3,  FWP
3/10/176-K
10/28/16424B2,  EFFECT
6/29/166-K
1/8/16
9/16/156-K
3/11/15UPLOAD
12/16/14
6/11/14
 List all Filings 
Top
Filing Submission 0001193125-18-337149   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 9, 9:54:49.1am ET